Home › Funds › NAVELLIER & ASSOCIATES INC › INDV

NAVELLIER & ASSOCIATES INC position in INDV

INDIVIOR PHARMACEUTICALS INC · Health Care

NAVELLIER & ASSOCIATES INC reported holding 180,229 shares of INDV (INDIVIOR PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$6.5M, representing 0.54% of its reported portfolio and ranking #43 among its reported holdings. NAVELLIER & ASSOCIATES INC has disclosed INDV holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)180.23K sh
Reported value held$6.46M
Portfolio Weight0.54%
First reportedQ4 2025
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How NAVELLIER & ASSOCIATES INC's INDV position evolved

NAVELLIER & ASSOCIATES INC first disclosed a stake in INDV in Q4 2025 at 114,904 shares (US$4.1M). The position peaked in Q2 2026 at 173,860 shares, worth US$7.1M. Across 4 filings, NAVELLIER & ASSOCIATES INC increased the stake 3 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 180,229 shares valued at US$6.5M — an increase of 6,369 shares quarter over quarter.. Notable position changes include a 30% increase in Q2 2026 (shares fell 13% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 114.90K $4.12M New
Q1 2026 134.11K $4.09M Add
Q2 2026 173.86K $7.13M Add
Q3 2026 180.23K $6.46M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About INDV and 13F data

INDV (INDIVIOR PHARMACEUTICALS INC) is a Health Care company. 51 other funds we track also report a position in INDV — the largest reported positions include OAKTREE CAPITAL MANAGEMENT LP (US$251.4M), Two Seas Capital LP (US$131.6M), Madison Avenue Partners, LP (US$117.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding INDV

All INDV fund holders →

FAQ

How long has NAVELLIER & ASSOCIATES INC held INDV?

NAVELLIER & ASSOCIATES INC has disclosed INDV holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is NAVELLIER & ASSOCIATES INC's current position in INDV?

As of Q3 2026, NAVELLIER & ASSOCIATES INC holds 180.23K shares of INDV (INDIVIOR PHARMACEUTICALS INC), valued at $6.46M, representing 0.54% of its reported portfolio and ranking #43.

Has NAVELLIER & ASSOCIATES INC been buying or selling INDV?

In the latest 13F filing (Q3 2026), NAVELLIER & ASSOCIATES INC increased its position in INDV. The position peaked in Q2 2026 at 173.86K shares.

Which other funds hold INDV?

Other major institutional holders of INDV include OAKTREE CAPITAL MANAGEMENT LP, Two Seas Capital LP, Madison Avenue Partners, LP, among 51 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.